(Q40647627)

22 September 2017

title

Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies (English)

1 reference

22 September 2017

D L Hazel

1

1 reference

22 September 2017

J Graham

2

1 reference

22 September 2017

J P Dickinson

3

1 reference

22 September 2017

A C Newland

4

1 reference

22 September 2017

S M Kelsey

5

1 reference

22 September 2017

publication date

1 August 1997

1 reference

22 September 2017

published in

Journal of Chemotherapy

1 reference

22 September 2017

volume

9

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

267-272

1 reference

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.4.267

Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.4.267

Antimicrobial-drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.4.267

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.4.267

Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.4.267

21 January 2018

Identifiers

DOI

10.1179/JOC.1997.9.4.267

1 reference

22 September 2017

1 reference